24 March 2017
Scientists from the Institute will receive funding from Cancer Research UK to develop new treatments for pancreatic cancer using a network of clinical trials.
 
20 March 2017
Professor Richard Marais will receive one of the most prestigious European awards for cancer research: the Léopold Griffuel Award in Translational and Clinical Research.
 
20 January 2017
CRT Pioneer Fund will further develop RET inhibitors through a collaboration with our Drug Discovery Unit.
 
21 December 2016
Researchers discover a subset of CTCs express a vascular endothelial cadherin associated with vasculogenic mimicry.
 
06 December 2016
CRUK Manchester Institute has been recognised for helping to further the communication of animal research in the UK.
 
21 November 2016
A blood test could predict how well small-cell lung cancer (SCLC) patients will respond to treatment.
 
09 November 2016
Using blood the study shows how in future tumour evolution could be monitored without invasive biopsies.
 
07 October 2016
CRT has received a success payment from GlaxoSmithKline resulting from its collaboration developing molecules targeting cancer epigenetics.
 
03 October 2016
Tim Somervaille, researcher and honorary consultant, has been honoured with a professorship from The University of Manchester
 
13 September 2016
Allan Jordan has received a national award from Cancer Research UK in recognition of his outstanding contribution to the cause.
 
02 September 2016
Researchers show how hypoxia in cancer cells can shift protein-coding genes into becoming non-coding ‘dark matter’.
 
16 August 2016
Our scientists explain some of the contradictory behaviour of Rac1.
 
12 August 2016
Dr Amaya Virós wins the Gold Award from LEO Pharma Research Foundation for exceptional contributions to dermatology research.
 
01 August 2016
Our scientists have shown that a pair of proteins involved in the development of blood cells may have different roles to play, with one apparently much more implicated in certain types of leukaemia.
 
18 July 2016
Anne Largeot wins Best Poster Award at the XXI Wilsede “Modern Trends in Human Leukemia and Cancer” meeting.
 
15 July 2016
Soapbox Science is back in Manchester and cancer researchers from the Cancer Research UK Manchester Institute are taking part.
 
13 July 2016
The Cancer Research UK Manchester Institute will be a partner in a new European Consortium to foster research on metastatic uveal melanoma and identify new treatments for this serious disease.
 
09 July 2016
Cancer experts from around Europe converge on Manchester to share expertise with our world-leading scientists at a special Congress.
 
04 July 2016
Emma Williams was awarded Best Talk Prize at the 10th International PhD Student Cancer Conference.
 
29 June 2016
Professor Caroline Dive will work with a team from the US to radically accelerate progress against cancer, in one of the first international collaborations inspired by US Vice President Joe Biden’s Cancer Moonshot.
 
27 June 2016
Professor Caroline Dive has recently been awarded a prestigious British Pharmaceutical Society prize.
 
22 May 2016
Our scientists will play a key role in ground-breaking research into the final stages of cancer.
 
13 May 2016
A breakthrough study sheds light on how cancer cells and normal cells communicate with each other and could open up new approaches to cancer treatment.
 
02 May 2016
Caroline Dive is a team member shortlisted to develop a method for generating personalised 4D atlases of cancers.
 
14 April 2016
Dr Amaya Virós, a clinician scientist, has been awarded a Wellcome Trust Intermediate Clinician Scientist Fellowship.
 
08 April 2016
Dr Maria Romina Girotti is one of four exceptional early career researchers honoured in the 2017 Awards.
 
07 April 2016
Our scientists have identified a potential double drug combination against B-cell acute lymphoblastic leukaemia.
 
22 March 2016
Our researchers have identified mutations in lung cancer that are key to tumour growth, offering a new way to differentiate and treat some patients with the disease.
 
07 March 2016
A blood test may be able to sound early warning bells that patients with advanced melanoma skin cancer are relapsing.
 
10 February 2016
Our scientists have explored the role of one particular cell signalling protein in bowel cancer, and found that its mutation promotes tumour growth.
 
09 February 2016
Research led by Dr Claus Jørgensen has identified a protein that controls how breast cancer cells spread around the body.
 
04 February 2016
Dr Claus Jørgensen is one of six scientists to have new research projects funded by Pancreatic Cancer Research Fund (PCRF).
 
29 January 2016
Scientists from our Institute have found that certain melanoma cells change the way they produce energy for growth, offering an insight into drug resistance and a potential way to treat resistant tumours in the clinic.
 
14 December 2015
Tim Somerville is the winner of the Institute’s Dexter Award for Young Scientists for 2015.
 
27 November 2015
John Brognard was awarded a prestigious Cancer Research UK ‘Future Leaders in Cancer Research’ prize.
 
26 November 2015
Romina Girotti, a postdoctoral fellow in the Molecular Oncology group, has received a British Association for Cancer Research (BACR) Translational Award
 
23 November 2015
Institute Director Professor Richard Marais has been elected to the Academia Europaea.
 
24 September 2015
Our scientists have identified a gene – FOXC1 – that, if switched on, causes more aggressive cancer in a fifth of acute myeloid leukaemia (AML) patients
 
07 September 2015
Dr Romina Girotti, from the Molecular Oncology group, has been awarded the Young Investigator’s Award by ECCO.
 
16 August 2015
Researchers have developed a robust blood test to identify key molecules that help tumour cells produce energy, thereby supporting cancer growth.
 
02 August 2015
Research suggests how resistance against a new lung cancer treatment might be overcome.
 
14 July 2015
Our scientists have genetically mapped the cancer of a leukaemia patient whose disease was resistant to treatment in order to identify a method of personalising therapy for individuals.
 
26 June 2015
A new £28.5m research centre that will transform cancer treatment has opened in Manchester.
 
11 May 2015
Professor Caroline Dive has joined the ranks of eminent UK scientists and become a Fellow of the prestigious Academy of Medical Sciences.
 
13 April 2015
Melanoma cells become drug resistant by using surrounding healthy cells to provide a ‘safe haven’ from treatment.
 
06 April 2015
Professor Caroline Dive is part of CANCER-ID, a newly formed European consortium funded by the Innovative Medicines Initiative (IMI) aiming to establish standard protocols for clinical validation of blood-based biomarkers.
 
01 April 2015
A group of academic organisations and funders has entered an agreement with biopharmaceutical company Basilea Pharmaceutica Ltd. to progress a new family of cancer drugs designed to block several key cancer-causing proteins at once.
 
25 March 2015
Researchers have provided early evidence to suggest that a blood test could be used to identify bowel cancer patients that may benefit from more intensive chemotherapy.
 
15 March 2015
Caroline Dive wins an International Women’s Day Award in recognition of her pioneering work on circulating biomarkers and the development of minimally invasive biopsies for cancer patients.
 
09 March 2015
Our researchers, working with scientists in California, have found that certain molecules long thought to promote cancer growth, in fact suppress tumours, suggesting that therapeutic approaches should aim to restore, rather than block, their activity.
 
23 February 2015
Romina Girotti is attending Parliament to present her science to a range of politicians and a panel of expert judges, as part of SET for Britain on Monday 9 March.
 
11 February 2015
Romina Girotti was recently awarded a grant to present at the EACR-OECI Conference on Precision Medicine for Cancer, 1 – 4 March 2015.
 
10 February 2015
Clinical and Experimental Pharmacology is awarded a poster prize at the British Thoracic Oncology Group 2015 Meeting.
 
09 February 2015
Stem cell researchers have developed a method to create blood cells that perfectly match individual patients, offering a new treatment approach for blood cancers and other diseases.
 
02 February 2015
Computer scientists have proposed a new approach to linking together the wealth of data generated by cancer research
 
12 January 2015
Scientists at the Cancer Research UK Manchester Institute have recently explored the role of a protein in regulating tumour development and found that it suppresses liver cancer growth in the lab.
 
02 January 2015
Researchers have revealed a brand new family of cancer drugs designed to block several key cancer-causing proteins at once could potentially treat incurable skin cancers.
 
22 December 2014
Research led by Dr Angeliki Malliri has shown microscopic images revealing that the protein ties tethering cells together are severed in lung cancer cells – meaning they can break loose and spread.
 
11 December 2014
Our scientists are benefitting from a major makeover of tissue-based research facilities that we can use for ground-breaking research.
 
21 November 2014
The Cancer Research Technology Pioneer Fund announces its collaboration with the Drug Discovery Unit to develop a promising class of drugs called RET inhibitors to treat cancer.
 
14 November 2014
Scientists at The Cancer Research UK Manchester Institute have found more than 400 ‘blind spots’ in DNA which could hide cancer-causing gene faults.
 
07 November 2014
Scientists have developed a new method to quickly and more accurately investigate vital cell communication – a process that often goes wrong in cancer.
 
20 October 2014
Dr Esther Baena teamed up with a Pennsylvanian fashion designer to create a dress showing how prostate cancer spreads in the body.
 
29 September 2014
We wish to congratulate Romina Girotti of the Molecular Oncology group who has won a $1000 travel award from the Society for Melanoma Research.
 
27 August 2014
Professor Richard Marais and his team in Molecular Oncology have discovered that acral melanomas – the rare type of skin cancer that caused reggae musician Bob Marley’s death – are genetically distinct from other more common types of skin cancer.
 
25 August 2014
Dr Claus Jørgensen, head of the Systems Oncology group, together with researchers from the Institute of Cancer Research, have shown how to better identify and measure vital molecules that control cell behaviour.
 
12 August 2014
Professor Iain Hagan and his team in the Cell Division group work on yeast to study fundamental biological processes – potentially giving a greater insight into what goes wrong in cancer.
 
08 August 2014
Professor Richard Marais is now the President of the European Association of Cancer Research
 
14 July 2014
Dr Crispin Miller, head of the RNA Biology group, is investigating how yeast cells respond to environmental stress in order to gain insight into processes that could help our understanding of cancer development.
 
03 July 2014
Cancer Research UK has brought together leading researchers from Manchester and London in the creation of a groundbreaking new Lung Cancer Centre of Excellence, launched on 1 July 2014.
 
12 June 2014
The Molecular Oncology team have shown that sunscreen cannot be relied upon alone to prevent malignant melanoma, the most deadly form of skin cancer, according to their research published in Nature.
 
11 June 2014
The journal Clinical Cancer Research has recently published work undertaken by the Clinical and Experimental Pharmacology (CEP) group on the potential use of an experimental drug, AZD3965, in the treatment of Small Cell Lung Cancer (SCLC).
 
04 June 2014
A study by our researchers in the Molecular Oncology group has shown how melanoma drugs can cause the cancer to progress once a patient has stopped responding to treatment.
 
02 June 2014
Our scientists have shown how a lung cancer patient’s blood sample could be used to monitor and predict their response to treatment – paving the way for personalised medicine for the disease.
 
02 June 2014
RAPID RESISTANCE to vemurafenib – a treatment for a type of advanced melanoma, the deadliest form of skin cancer – could be prevented by blocking a druggable family of proteins, according to research published in Nature Communications by the Institute’s scientists.
 
16 May 2014
Our scientists have discovered a molecule that plays a key role in leukaemia, a protein called PIP4K2A that could be a new target in drug development.
 
12 March 2014
Two new group leaders are set to join the Cancer Research UK Manchester Institute at The University of Manchester – part of the Manchester Cancer Research Centre.
 
07 March 2014
We are very excited to announce the launch of the Movember Centre of Excellence, in partnership with Prostate Cancer UK, a joint enterprise between the Cancer Research UK Manchester Institute and Queen’s University Belfast
 
29 January 2014
Scientists at the Cancer Research UK Manchester Institute have gained new insight into a possible treatment target for leukaemia by looking at what makes blood stem cells stop replicating.
 
28 January 2014
We are delighted to announce that PhD student Eva Barkauskaite, formerly of the DNA Damage Response group, has been selected as the winner of the Cancer Research UK Manchester Institute Dexter Award for Young Scientists for 2013.
 
20 December 2013
We are delighted to announce that our Director of the Institute, Professor Richard Marais, has been awarded the second Griem Lectureship in Molecular and Cellular Oncology from University of Chicago Comprehensive Cancer Center (UCCCC), in recognition for his outstanding contribution to the field of melanoma research that has advanced the development of targeted therapies against melanoma.
 
19 December 2013
We wish to warmly congratulate Dr Angeliki Malliri, head of the Cell Signalling Group, for her successful grant application to the Medical Research Council.
 
19 December 2013
The Molecular Oncology group, led by Professor Richard Marais, has performed the first whole genome sequencing of uveal melanoma, a disease that affects the iris and other pigmented parts of the eye.
 
13 August 2013
A new era in lung cancer research has been unveiled in a world-first Cancer Research UK study that will track, in real time, how lung cancers mutate, adapt and develop resistance as patients receive treatment.
 
08 July 2013
A new efficient screening strategy has been developed that can identify faulty genes in tumour cells that are possible drug targets for the most common form of lung cancer, according to research published in PNAS on 8 July 2013.
 
18 March 2013
Adding lung cancer drugs to targeted melanoma treatment could increase survival for certain patients, according to research published in Cancer Discovery on 11 February 2013.
 
19 February 2013
Professor Richard Marais, Director of the Paterson Institute for Cancer Research and head of the Molecular Oncology Group, is a world leader in melanoma research.
 
13 December 2012
Professor Caroline Dive, Lead of the Clinical and Experimental Pharmacology Group (CEP), has been awarded the 2012 Pasteur-Weizmann/Servier International Prize in recognition of her pioneering studies in the identification of new serum based biomarkers and for the development of non-invasive procedures in the early diagnosis and management of cancer.
 
12 December 2012
Caroline Dive, Ged Brady and Kyaw Aung from the Clinical and Experimental Pharmacology Group (CEP), together with Pancreatic Specialist Oncologists at the Christie Hospital, Juan Valle and Richard Hubner, have recently been awarded substantial financial support by the Pancreatic Cancer Research Fund.
 
11 December 2012
Georges Lacaud, Stem Cell Biology Group Leader, has been awarded significant funding by Leukaemia & Lymphoma Research to undertake a three-year project to identify and characterise genes regulated by MOZ and MOZ-TIF2.
 
20 June 2012
Congratulations to Alexia Eliades who has been awarded an EMBO Post-Doctoral Fellowship.
 
12 January 2012
Angeliki Malliri, head of the Cell Signalling Group, has been awarded two research grants.
 
12 January 2012
Ahmet Acar from the Stromal-Tumour Interaction Group, led by Dr Akira Orimo, was runner up in the best student poster competition at the recent NCRI conference in Liverpool.
 
15 November 2011
A team of researchers from Manchester was yesterday awarded the 2011 Cancer Research UK Prize for Translational Cancer Research at the NCRI Cancer Conference in Liverpool.
 
15 November 2011
Professor Caroline Dive from the Paterson Institute has recently been elected a Fellow of the European Academy of Cancer Sciences. Hosted under the auspices of ECCO (European CanCer Organisation), the Academy strives for excellence, independence, leadership, diversity and flexibility.
 
07 November 2011
Dr Ivan Ahel, a Junior Group Leader at the Paterson Institute, was one of 22 scientists selected to become members of the European Molecular Biology Organisation (EMBO) Young Investigator Programme.
 
22 September 2011
Cancer Research UK and The University of Manchester have appointed Professor Richard Marais to be the next director of the Paterson Institute for Cancer Research in Manchester.